Bio-Rad Labs (BIO) Issues Q3 EPS of $1.61, Beats by 8c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $282.44 --0%
EPS Growth %: -30.7%
Financial Fact:
Research and development expense: 52.17M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -30.7%
Financial Fact:
Research and development expense: 52.17M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Bio-Rad Laboratories Inc. (NYSE: BIO) reported Q3 EPS of $1.61, $0.08 better than the analyst estimate of $1.53. Revenue for the quarter came in at $516.5 million versus the consensus estimate of $511.47 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
- Sonoma Pharmaceuticals (SNOA) Misses Q4 EPS by 33c
- Safe Bulkers (SB) Tops Q1 EPS by 7c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
